Skip to main content

Research Repository

Advanced Search

Bio-impedance spectroscopy added to a fluid management protocol does not improve preservation of residual kidney function in incident hemodialysis patients in a randomized controlled trial.

Davies, Simon J; Coyle, David; Lindley, Elizabeth J; Keane, David; Belcher, John; Caskey, Fergus J; Dasgupta, Indranil; Davenport, Andrew; Farrington, Ken; Mitra, Sandip; Ormandy, Paula; Wilkie, Martin; Macdonald, Jamie; Zanganeh, Mandana; Andronis, Lazaros; Solis-Trapala, Ivonne; Sim, Julius

Bio-impedance spectroscopy added to a fluid management protocol does not improve preservation of residual kidney function in incident hemodialysis patients in a randomized controlled trial. Thumbnail


Authors

Simon J Davies

David Coyle

Elizabeth J Lindley

David Keane

John Belcher

Fergus J Caskey

Indranil Dasgupta

Andrew Davenport

Ken Farrington

Sandip Mitra

Martin Wilkie

Jamie Macdonald

Mandana Zanganeh

Lazaros Andronis

Ivonne Solis-Trapala

Julius Sim



Abstract

Avoiding excessive dialysis-associated volume depletion may help preserve residual kidney function (RKF). To establish whether knowledge of the estimated normally hydrated weight from bioimpedance measurements (BI-NHW) when setting the post-hemodialysis target weight (TW) might mitigate rate of loss of RKF, we undertook an open label, randomized controlled trial in incident patients receiving HD, with clinicians and patients blinded to bioimpedance readings in controls. A total of 439 patients with over 500 ml urine/day or residual GFR exceeding 3 ml/min/1.73m were recruited from 34 United Kingdom centers and randomized 1:1, stratified by center. Fluid assessments were made for up to 24 months using a standardized proforma in both groups, supplemented by availability of BI-NHW in the intervention group. Primary outcome was time to anuria, analyzed using competing-risk survival models adjusted for baseline characteristics, by intention to treat. Secondary outcomes included rate of RKF decline (mean urea and creatinine clearance), blood pressure and patient-reported outcomes. There were no group differences in cause-specific hazard rates of anuria (0.751; 95% confidence interval (0.459, 1.229)) or sub-distribution hazard rates (0.742 (0.453, 1.215)). RKF decline was markedly slower than anticipated, pooled linear rates in year 1: -0.178 (-0.196, -0.159)), year 2: -0.061 (-0.086, -0.036)) ml/min/1.73m /month. Blood pressure and patient-reported outcomes did not differ by group. The mean difference agreement between TW and BI-NHW was similar for both groups, Bioimpedance: -0.04 kg; Control: -0.25 kg. Thus, use of a standardized clinical protocol for fluid assessment when setting TW is associated with excellent preservation of RKF. Hence, bioimpedance measurements are not necessary to achieve this. [Abstract copyright: Copyright © 2023 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.]

Citation

Davies, S. J., Coyle, D., Lindley, E. J., Keane, D., Belcher, J., Caskey, F. J., …Sim, J. (2023). Bio-impedance spectroscopy added to a fluid management protocol does not improve preservation of residual kidney function in incident hemodialysis patients in a randomized controlled trial. Kidney International, 104(3), S0085-2538(23)00394-0. https://doi.org/10.1016/j.kint.2023.05.016

Journal Article Type Article
Acceptance Date May 18, 2023
Online Publication Date May 30, 2023
Publication Date 2023-09
Deposit Date Jul 5, 2023
Publicly Available Date Apr 10, 2024
Journal Kidney international
Print ISSN 0085-2538
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 104
Issue 3
Pages S0085-2538(23)00394-0
DOI https://doi.org/10.1016/j.kint.2023.05.016
Keywords anuria, patient-reported outcomes, bioimpedance spectroscopy, fluid status, residual kidney function, blood pressure

Files




You might also like



Downloadable Citations